LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Study Reveals Mechanism Protecting UTI Bacteria from Nitric Acid Damage

By LabMedica International staff writers
Posted on 08 Nov 2016
Image: Cytochrome bd-I tagged with Green Fluorescent Protein can be visualized in the membrane of E. coli (Photo courtesy of Dr. Mark Shepherd, University of Kent).
Image: Cytochrome bd-I tagged with Green Fluorescent Protein can be visualized in the membrane of E. coli (Photo courtesy of Dr. Mark Shepherd, University of Kent).
A team of molecular microbiologists has identified the enzyme cytochrome bd-I oxidase as promoting urinary tract infections by being of critical importance in protecting E. coli bacteria from the effects of nitric oxide generated by the host's immune response.

Nitric oxide (NO) is a toxic free radical produced by neutrophils and macrophages in response to infection. Uropathogenic Escherichia coli (UPEC) generate a variety of defence mechanisms in response to NO, including direct NO detoxification, iron-sulphur cluster repair, and the expression of the NO-tolerant cytochrome bd-I respiratory oxidase.

Investigators at the University of Kent (United Kingdom) and colleagues at the University of Queensland (Brisbane, Australia) quantified the relative contribution of these systems to UPEC growth and survival during infection.

They reported in the October 21, 2016, online edition of the journal Scientific Reports that while UPEC have acquired a host of specialized mechanisms to evade NO-based stresses, the cytochrome bd-I respiratory oxidase was the main contributor to NO tolerance and host colonization under microaerobic conditions. Since cytochrome bd-I is absent in humans, drugs designed to target this enzyme would be less likely to be toxic to human cells.

Related Links:
University of Kent
University of Queensland

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more